Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.74%49.09M | 3.98%49.15M | 8.37%48.35M | 9.61%173.23M | 5.41%42.79M | 19.30%52.08M | 13.80%47.26M | -5.85%44.61M | -7.53%158.05M | -4.54%40.6M |
| Cost of revenue | -7.25%21.05M | 9.25%21.19M | 5.79%20.62M | -2.09%31.55M | -7.50%18.13M | 15.47%22.69M | 4.66%19.39M | 7.40%19.49M | -4.12%32.23M | 197.11%19.6M |
| Gross profit | -4.57%28.04M | 0.32%27.96M | 10.38%27.73M | 12.60%141.68M | 17.45%24.67M | 22.44%29.38M | 21.16%27.87M | -14.06%25.12M | -8.36%125.82M | -66.51%21M |
| Operating expense | -134.45%-1.06M | -141.04%-1.24M | -361.38%-1.25M | 22.23%38.88M | -121.20%-2.47M | 1,289.15%3.07M | 618.73%3.02M | -89.52%479K | -34.02%31.81M | -102.52%-1.12M |
| Staff costs | ---- | ---- | ---- | 3.48%12.99M | ---- | ---- | ---- | ---- | 9.75%12.55M | ---- |
| Selling and administrative expenses | -63.46%2.23M | -54.46%2.14M | -4.38%2.12M | 25.95%15.15M | 12.28%2.14M | 205.51%6.1M | 144.25%4.7M | -64.31%2.21M | 6,973.53%12.03M | 122.88%1.91M |
| -General and administrative expense | -63.46%2.23M | -54.46%2.14M | -4.38%2.12M | 25.95%15.15M | 12.28%2.14M | 205.51%6.1M | 144.25%4.7M | -64.31%2.21M | 6,973.53%12.03M | 122.88%1.91M |
| Depreciation and amortization | ---- | ---- | ---- | 7.49%23.42M | ---- | ---- | ---- | ---- | 0.32%21.79M | ---- |
| -Depreciation | ---- | ---- | ---- | 7.49%23.42M | ---- | ---- | ---- | ---- | 0.32%21.79M | ---- |
| Other operating expenses | ---- | ---- | ---- | 25.72%26.88M | ---- | ---- | ---- | ---- | 43.07%21.38M | ---- |
| Total other operating income | 8.49%3.28M | 101.31%3.38M | 94.23%3.37M | 2.08%24.41M | 52.55%4.61M | 34.35%3.03M | -33.01%1.68M | 6.25%1.73M | 3,098.48%23.91M | 178.23%3.02M |
| Operating profit | 10.57%29.1M | 17.49%29.2M | 17.61%28.98M | 9.34%102.8M | 22.69%27.14M | 8.49%26.32M | 5.37%24.85M | -0.09%24.65M | 5.52%94.01M | 20.31%22.12M |
| Net non-operating interest income (expenses) | 1.32%-3.3M | -20.29%-3.61M | -23.44%-3.87M | -5.40%-13.47M | -27.10%-4.15M | 3.18%-3.35M | 14.44%-3M | 1.29%-3.14M | -26.93%-12.78M | -30.03%-3.27M |
| Non-operating interest income | ---- | ---- | ---- | -74.81%155.26K | ---- | ---- | ---- | ---- | -13.13%616.46K | ---- |
| Non-operating interest expense | -1.32%3.3M | 20.29%3.61M | 23.44%3.87M | 0.86%13.51M | 27.10%4.15M | -3.18%3.35M | -14.44%3M | -1.29%3.14M | 24.30%13.39M | 1.62%3.27M |
| Total other finance cost | ---- | ---- | ---- | 1,296.04%122.6K | ---- | ---- | ---- | ---- | 18.34%8.78K | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 12.30%25.79M | 17.11%25.59M | 16.75%25.11M | 9.97%89.32M | 21.93%22.99M | 10.43%22.97M | 8.82%21.86M | 0.09%21.51M | -2.90%81.23M | -8.04%18.85M |
| Income tax | 13.16%5.93M | 37.17%5.7M | 39.80%5.35M | 13.55%18.3M | 229.48%5.07M | 25.08%5.24M | 2.34%4.16M | -39.48%3.83M | -31.81%16.12M | -66.89%1.54M |
| Net income | 12.04%19.86M | 12.40%19.89M | 11.77%19.76M | 9.08%71.02M | 3.47%17.91M | 6.73%17.73M | 10.47%17.7M | 16.59%17.68M | 8.49%65.11M | 9.23%17.31M |
| Net income continuous operations | 12.04%19.86M | 12.40%19.89M | 11.77%19.76M | 9.08%71.02M | 3.47%17.91M | 6.73%17.73M | 10.47%17.7M | 16.59%17.68M | 8.49%65.11M | 9.23%17.31M |
| Noncontrolling interests | -56.25%7K | 0.00%7K | -20.00%4K | 8.36%29.51K | 0.00%2K | 14.29%16K | 40.00%7K | -16.67%5K | 58.15%27.24K | 212.42%2K |
| Net income attributable to the company | 12.11%19.86M | 12.40%19.89M | 11.78%19.76M | 9.08%70.99M | 3.47%17.91M | 6.72%17.71M | 10.46%17.69M | 16.60%17.68M | 8.47%65.08M | 9.21%17.31M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.11%19.86M | 12.40%19.89M | 11.78%19.76M | 9.08%70.99M | 3.47%17.91M | 6.72%17.71M | 10.46%17.69M | 16.60%17.68M | 8.47%65.08M | 9.21%17.31M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 6.21%0.0171 | 9.32%0.0176 | 10.56%0.0178 | 8.04%0.0645 | 2.53%0.0162 | 7.33%0.0161 | 9.52%0.0161 | 14.18%0.0161 | 3.83%0.0597 | 16.46%0.0158 |
| Diluted earnings per share | 8.44%0.0167 | 10.46%0.0169 | 10.46%0.0169 | 5.57%0.0607 | 4.05%0.0154 | 9.22%0.0154 | 10.87%0.0153 | 13.33%0.0153 | 1.77%0.0575 | 17.77%0.0148 |
| Dividend per share | 0.00%0.005 | -33.33%0.005 | 0.00%0.005 | 12.50%0.0225 | 0.00%0.005 | 0.00%0.005 | 50.00%0.0075 | 0.00%0.005 | -4.00%0.02 | 0.00%0.005 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.